| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 11/11/2008 | US7449301 Pharmaceutical composition and method for activating macrophage using the same |
| 11/11/2008 | US7449300 Withdrawing a body fluid from a subject, wherein the body fluid comprises one or more antibodies that bind to B7-H1;removing from the body fluid a substantial portion of the one or more antibodies; returning the body fluid to the subject |
| 11/11/2008 | US7449191 Compositions and methods for detection of Ehrlichia canis and Ehrlichia chaffeensis antibodies |
| 11/11/2008 | US7449186 administering monoclonal antibodies to vascular cell adhesion mollecules (VCAM-1), to decrease VCAM-1 mediated adhesion between the bone marrow stromal cell and the cell expressing very late antigen-4 (VLA-4); immunomodulation to promote lymphocyte adhesion to endothelial cells |
| 11/11/2008 | US7449185 Immunoglobulin which binds osteoclastogenesis inhibitory factor binding molecules (OBM)) and prevents bone resorption for use in treatment and prevention of bone disorders |
| 11/11/2008 | US7449184 treating cancer in humans comprising administering oncogene monoclonal antibodies, such as pertuzumab |
| 11/11/2008 | US7449183 Endothelialization of vascular surfaces |
| 11/11/2008 | US7449181 Remedies for cancer |
| 11/11/2008 | US7449176 Treatment of inflammatory bowel disease with IFN-γ inhibitors |
| 11/06/2008 | WO2008134659A2 Antagonists to il-17a, il-17f, and il-23p19 and methods of use |
| 11/06/2008 | WO2008134046A1 Potent, stable and non-immunosuppressive anti-cd4 antibodies |
| 11/06/2008 | WO2008134034A1 Prion protein as a receptor for amyloid-beta oligomers |
| 11/06/2008 | WO2008133857A1 Anti-mdl-1 antibodies |
| 11/06/2008 | WO2008133851A1 Methods and compositions for the treatment of prostate cancer |
| 11/06/2008 | WO2008133722A2 Anti human sclerostin antibodies |
| 11/06/2008 | WO2008133684A1 Antibodies that bind both il-17a and il-17f and methods of using the same |
| 11/06/2008 | WO2008133651A2 Ablative immunotherapy |
| 11/06/2008 | WO2008132709A1 Products for altering il-33 activity and methods therefor |
| 11/06/2008 | WO2008132601A1 Cytotoxic anti-lag-3 monoclonal antibody and its use in the treatment or prevention of organ transplant rejection and autoimmune disease |
| 11/06/2008 | WO2008132568A2 Fusion proteins binding to growth factors |
| 11/06/2008 | WO2008132516A1 Toll-like receptor binding epitope and compositions for binding thereto |
| 11/06/2008 | WO2008132453A1 Antibodies against ramp3 |
| 11/06/2008 | WO2008132152A1 Novel antibody molecules and nucleic acids binding to fungal stress protein hsp90 |
| 11/06/2008 | WO2008132134A1 Novel antibody molecules and nucleic acids binding to fungal stress protein hsp90 |
| 11/06/2008 | WO2008131940A2 Combination of immunological agent and sensitizing agent for the treatment of cancer |
| 11/06/2008 | WO2008131575A2 Anti-alk antibodies suitable for treating metastatic cancers or tumors |
| 11/06/2008 | WO2008116149A3 Apoptotic anti- ige antibodies binding the membrane-bound ige |
| 11/06/2008 | WO2008115750A3 Compositions and methods for the treatment of cancer |
| 11/06/2008 | WO2008115061A3 Dual targeting system |
| 11/06/2008 | WO2008105773A3 System for targeted delivery of therapeutic agents |
| 11/06/2008 | WO2008103920A3 Targeted protein cages |
| 11/06/2008 | WO2008091911A3 Use of antibody conjugates |
| 11/06/2008 | WO2008086006A3 Sp35 antibodies and uses thereof |
| 11/06/2008 | WO2008085900A3 Methods for generating novel stabilized proteins |
| 11/06/2008 | WO2008077022A3 Himf and btk in pulmonary, cardiac, and inflammation disorders |
| 11/06/2008 | WO2008073984A3 Nmdar biomarkers for diagnosing and treating cerebral ischemia |
| 11/06/2008 | WO2008073174A3 Antimicrobial therapy |
| 11/06/2008 | WO2008063479A3 Pancreatic cancer biomarkers |
| 11/06/2008 | WO2008060367A3 Human antibodies that bind cxcr4 and uses thereof |
| 11/06/2008 | WO2008057240A3 Crystalline anti-htnfalpha antibodies |
| 11/06/2008 | WO2008042754A3 Design and construction of diverse synthetic peptide and polypeptide libraries |
| 11/06/2008 | WO2008019305A3 Improved synthesis of labeled probes |
| 11/06/2008 | WO2008017963A3 Antigen binding molecules that bind egfr, vectors encoding same, and uses thereof |
| 11/06/2008 | WO2007124299A8 Antagonist anti-cd40 antibody pharmaceutical compositions |
| 11/06/2008 | WO2007106762A3 Alzheimer's disease biomarkers and methods of use |
| 11/06/2008 | WO2007089601A3 Nogo receptor antagonists |
| 11/06/2008 | WO2005003775A9 Glycoconjugates and their use as potential vaccines against infection by shigella flexneri |
| 11/06/2008 | WO2004078938A3 Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof |
| 11/06/2008 | US20080275376 Method for enhancing immune responses in mammals |
| 11/06/2008 | US20080275221 Busulfan Immunoassay |
| 11/06/2008 | US20080275220 Securing polypeptide solution against exogenous stress via filling containers so as to prevent formation of gaseous headspace |
| 11/06/2008 | US20080275214 Viral peptides for use in activating immune response to treat and prevent viral infection |
| 11/06/2008 | US20080274994 Dna sequence and genomic structure of human cardiac isoform; gene or allele mutants associated with cardiovascular disorders; reduce stretch activation and adjust tension of muscles in heart contraction; isolated nucleic acid encoding a protein |
| 11/06/2008 | US20080274990 Cog47 Protein and S100beta Gene Polymorphism |
| 11/06/2008 | US20080274970 Vascular adhesion molecules and modulation of their function |
| 11/06/2008 | US20080274967 Variants of Pigment Epithelium Derived Factor and Uses Thereof |
| 11/06/2008 | US20080274958 Glycosylation of peptides via o-linked glycosylation sequences |
| 11/06/2008 | US20080274954 Novel protein; rho genes rho proteins; guanosine triphosphate binding proteins; antibody against the protein encodes polynucleotide; detection; determinating esophagual cancer |
| 11/06/2008 | US20080274542 Canine and feline 5T4 polypeptide sequences for use in generating vaccine for prevention and treatment of cell proliferative disorders; veterinary medicine |
| 11/06/2008 | US20080274506 Host cell comprising vector expressing protein fusion comprising neonatal Fc receptor for use in enhancing antibody-dependent cell-mediated cytotoxicity (ADCC) targeting of cancer cells |
| 11/06/2008 | US20080274502 Bacillus Thuringiensis CryET33 and CryET34 Compositions and Uses Therefor |
| 11/06/2008 | US20080274477 Forms of Factor Xiia |
| 11/06/2008 | US20080274472 Novel kinases and uses thereof |
| 11/06/2008 | US20080274468 Novel means for the diagnosis and therapy of ctcl |
| 11/06/2008 | US20080274145 whole cell or acellular vaccines against pathogenic Gram negatives such as Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica |
| 11/06/2008 | US20080274144 Genetically engineered or synthetically produced HCV (hepatitis C virus) E1 envelope proteins or parts thereof comprising disulfides between specific cysteine residues; viral-like particles; biodrugs |
| 11/06/2008 | US20080274133 Soluble Bifunctional Proteins |
| 11/06/2008 | US20080274131 Molecular antigen arrary |
| 11/06/2008 | US20080274124 Polyunsaturated fatty acids; kits |
| 11/06/2008 | US20080274123 Synaptic vesicle glycoprotein specific immunoglobulin for use in treatment and prevention of liver disorders; tissue targeted therapy |
| 11/06/2008 | US20080274115 Human estrogen specific immunoglobulin for use as evaluative tool in diagnosing/prognosing metastatic cancers; evaluating efficacy of anticancer treatment |
| 11/06/2008 | US20080274114 Anti-Egfr Antibodies |
| 11/06/2008 | US20080274113 Immunoglobulin specific to actin-myosin machinery of malarial parasite; prevention protozoal diseases |
| 11/06/2008 | US20080274112 Axonal growth receptor for use in designing immunoglobulins for prevention and treatment of nervous system, cardiovascular, vision and/or spinal cord injury |
| 11/06/2008 | US20080274111 Pancreatic Cancer Genes |
| 11/06/2008 | US20080274110 Minibodies for use in treatment and prevention of cell proliferative and/or autoimmune disorders |
| 11/06/2008 | US20080274109 Nucleotide sequences coding chemokines for use in dianosis of infection, arteriosclerosis, autoimmune, inflammatory, allergic and arthritic disorders |
| 11/06/2008 | US20080274108 Polypeptide variants with altered effector function |
| 11/06/2008 | US20080274106 Using interleukin-6 specific monoclonal antibody as therapeutic in treatment and prevention of lung cancer |
| 11/06/2008 | US20080274105 Polypeptide variants with altered effector function |
| 11/06/2008 | US20080274103 Adenylyl Cyclase Antibodies, Compositions and Uses Thereof |
| 11/06/2008 | US20080274102 Antibodies to Nik, Their Preparation and Use |
| 11/06/2008 | US20080274101 Stabilizing polypeptides which have been exposed to urea |
| 11/06/2008 | US20080274100 Chemokine receptors CCR5 or CXCR4 specific immunoglobulins for use in prevention and treatment of human immunodeficiency syndrome viral infection |
| 11/06/2008 | US20080274099 Oncofoetal domain specific immunoglobulin for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 11/06/2008 | US20080274077 Using Nogo receptor suppressant as therapeutic in treatment of nervous system and neurodegenerative disorders; axonal regeneration |
| 11/06/2008 | US20080274055 retain binding affinity for carcinoembryonic antigen; immunogenicity, compared to a parent antibody; vectors; host cells |
| 11/06/2008 | US20080274049 Cytotoxicity mediation of cells evidencing surface expression of CD44 |
| 11/06/2008 | US20080274047 producing antibodies which bind NK cell receptors for use in therapeutic strategies for treating immunoproliferative and autoimmune disorders |
| 11/06/2008 | US20080274045 Imaging, diagnosis and treatment of disease |
| 11/06/2008 | US20080273660 Compositions and Methods for Modulating DNA Repair |
| 11/06/2008 | DE102007020254A1 Use of an agent reducing the bioavailability of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to prepare a medicament, especially for treating allergic diseases |
| 11/06/2008 | CA2719878A1 Prion protein as a receptor for amyloid-beta oligomers |
| 11/06/2008 | CA2685584A1 Cytotoxic anti-lag-3 monoclonal antibody and its use in the treatment or prevention of organ transplant rejection and autoimmune disease |
| 11/06/2008 | CA2685295A1 Hemipteran- and coleopteran- active toxin proteins from bacillus thuringiensis |
| 11/06/2008 | CA2685136A1 Novel antibody molecules and nucleic acids binding to fungal stress protein hsp90 |
| 11/06/2008 | CA2685124A1 Products for altering il-33 activity and methods therefor |
| 11/06/2008 | CA2685099A1 Antibodies against ramp3 |
| 11/06/2008 | CA2685015A1 Anti-mdl-1 antibodies |
| 11/06/2008 | CA2683145A1 Antagonists to il-17a, il-17f, and il-23p19 and methods of use |